AMPK at the nexus of energetics and aging

K Burkewitz, Y Zhang, WB Mair - Cell metabolism, 2014 - cell.com
When energy supply is low, organisms respond by slowing aging and increasing resistance
to diverse age-related pathologies. Targeting the mechanisms underpinning this response …

AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity

HM O'Neill, GP Holloway, GR Steinberg - Molecular and cellular …, 2013 - Elsevier
Skeletal muscle plays an important role in regulating whole-body energy expenditure given
it is a major site for glucose and lipid oxidation. Obesity and type 2 diabetes are causally …

[HTML][HTML] The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation

G Mairet-Coello, J Courchet, S Pieraut, V Courchet… - Neuron, 2013 - cell.com
Summary Amyloid-β 1–42 (Aβ42) oligomers are synaptotoxic for excitatory cortical and
hippocampal neurons and might play a role in early stages of Alzheimer's disease (AD) …

AMP-activated protein kinase: new regulation, new roles?

D Carling, C Thornton, A Woods… - Biochemical …, 2012 - portlandpress.com
The hydrolysis of ATP drives virtually all of the energy-requiring processes in living cells. A
prerequisite of living cells is that the concentration of ATP needs to be maintained at …

Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease

JJ Siew, HM Chen, HY Chen, HL Chen… - Nature …, 2019 - nature.com
Huntington's disease (HD) is a neurodegenerative disorder that manifests with movement
dysfunction. The expression of mutant Huntingtin (mHTT) disrupts the functions of brain …

AMPK in the brain: its roles in glucose and neural metabolism

R Muraleedharan, B Dasgupta - The FEBS Journal, 2022 - Wiley Online Library
The adenosine monophosphate‐activated protein kinase (AMPK) is an integrative metabolic
sensor that maintains energy balance at the cellular level and plays an important role in …

Mitochondrial dysfunction in Huntington's disease

C Carmo, L Naia, C Lopes, AC Rego - Polyglutamine disorders, 2018 - Springer
Mitochondrial dysfunction has been described as an early pathological mechanism
delineating the selective neurodegeneration that occurs in Huntington's disease (HD), a …

A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington's disease

KP Chen, KF Hua, FT Tsai, TY Lin, CY Cheng… - Journal of …, 2022 - Springer
Background Huntington's disease (HD) is a neurodegenerative disorder caused by the
expansion of the CAG repeat in the huntingtin (HTT) gene. When the number of CAG …